Beijing Science Sun Pharmaceutical Co., Ltd. logo

Beijing Science Sun Pharmaceutical Co., Ltd. (300485)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
9. 94
+0.16
+1.636%
¥
5.55B Market Cap
- P/E Ratio
0.09% Div Yield
13.15M Volume
- Eps
¥ 9.78
Previous Close
Add Transaction
Day Range
9.65 10.01
Year Range
7.77 16.25
Want to track 300485 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300485 closed today higher at ¥9.94, an increase of 1.636% from yesterday's close, completing a monthly increase of 4.6316% or ¥0.44. Over the past 12 months, 300485 stock lost -6.0491%.
300485 pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next estimated payment will be in In 9 months on May 27, 2027 for a total of ¥0.03.
The last earnings report, released on Apr 30, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0835%, based on the last three reports.
Beijing Science Sun Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 29, 2018.
The company's stock is traded on one exchange.

300485 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Beijing Science Sun Pharmaceutical Co., Ltd. (300485) FAQ

What is the stock price today?

The current price is ¥9.94.

On which exchange is it traded?

Beijing Science Sun Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300485.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, the market cap is 5.55B.

Has Beijing Science Sun Pharmaceutical Co., Ltd. ever had a stock split?

Beijing Science Sun Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Jun 29, 2018.

Beijing Science Sun Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Biao Ma CEO
XSHE Exchange
CNE100002110 ISIN
CN Country
513 Employees
27 May 2026 Last Dividend
29 Jun 2018 Last Split
- IPO Date

Overview

Beijing Science Sun Pharmaceutical Co., Ltd. is a pioneering biopharmaceutical company based in Beijing, China, founded in 1999. The company dedicates itself to the research and development (R&D), production, and sales of injections, prominently focusing on the Chinese market. Its business operations extend beyond the production of pharmaceuticals to include the R&D and sale of raw materials, the extraction of traditional Chinese medicine, and the manufacturing of both Chinese and Western medicinal preparations. Additionally, Beijing Science Sun Pharmaceutical ventures into the breeding of livestock and poultry, the production of bio-organic fertilizers, and the development of bio-feed. The company further diversifies its portfolio by offering consulting services, engaging in venture capital activities, and participating in equity investments through private equity funds. This multifaceted approach allows them to contribute significantly to the pharmaceutical and biotechnological sectors, simultaneously exploring avenues in agriculture and consultancy.

Products and Services

  • Injections for Medical Use: Beijing Science Sun Pharmaceutical specializes in developing and manufacturing injections for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, catering to a range of crucial health concerns.
  • Raw Material Production: The company engages in the research, development, production, and sale of pharmaceutical raw materials, supporting the broader pharmaceutical manufacturing ecosystem.
  • Traditional Chinese Medicine: It contributes to the preservation and innovation within the field of traditional Chinese medicine through the extraction of key ingredients used in both Chinese and Western medicinal preparations.
  • Livestock and Poultry Breeding: Expanding its influence beyond pharmaceuticals, the company invests in the breeding of livestock and poultry, aiming to integrate bio-pharmaceutical advancements into agricultural practices.
  • Bio-Organic Fertilizer: The development and sale of bio-organic fertilizers represent the company’s commitment to sustainable agricultural practices, blending biotechnological research with environmental considerations.
  • Bio-Feed Research and Development: With a focus on enhancing the quality and efficiency of animal feed, Beijing Science Sun Pharmaceutical applies biotechnical research to develop superior bio-feed products.
  • Consultancy Services: The company offers expert consulting services, leveraging its extensive knowledge and experience in the biopharmaceutical industry to advise other enterprises and institutions.
  • Venture Capital and Equity Investments: Engaging in venture capital activities and equity investments, particularly through private equity funds, allows Beijing Science Sun Pharmaceutical to support innovation and growth within the industry.

Contact Information

Address: No.8, Xingsheng Street, Beijing, China, 100176
Phone: 86 10 6787 7178